loader2
Partner With Us NRI

Company details

79.00
85.25
28.95
119.30
6M Return 137.15%
1Y Return 113.91%
Mkt Cap.(Cr) 85.16
Volume 21,673
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 21,673

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 22.42 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,577.79
LAST 3M 77,375.96 -53,201.90
LAST 6M 142,231.38 -196,897.34
LAST 12M 206,053.08 -176,593.86
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
35.89
26.74%
23.2572
9.7%
3.38%
Description
  • Vaishali Pharma Limited was originally incorporated as a private limited company with the name `Vaishali Pharma Private Limited` on 25th, April 2008. On July 01, 2008 the company acquired the business of proprietorship concerns of its promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently business of this proprietorship firm was merged into Vaishali Pharma Private Limited. Subsequently the company was converted into a public limited company and the name of the company was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the promoters of the company. Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, the company has applied for 186 registrations in 13 countries for some of its product, out of which it has successfully received 71 approvals from 7 countries and in process of obtaining remaining approvals, which will give boost to export business operations.

Read More

Registered Address

706 to 709 7th Floor Aravali, Business Centre Borivali(W), Mumbai, Maharashtra, 400092

Tel : 91-22-28928833
Email : investor:vaishalipharma.com
Website : http://www.vaishalipharma.com

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 535000
NSE Code : VAISHALI
Book Closure Date (Month) : Sep
BSE Group :
ISIN : INE972X01014

ICICIdirect Vaishali Pharma Ltd FAQ

You can buy Vaishali Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vaishali Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 20, 2022 03:53 PM the closing price of Vaishali Pharma Ltd was ₹ 80.75.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 20, 2022 03:53 PM, the market cap of Vaishali Pharma Ltd stood at ₹ 85.16.
The latest PE ratio of Vaishali Pharma Ltd as of May 20, 2022 03:53 PM is 35.89
The latest PB ratio of Vaishali Pharma Ltd as of May 20, 2022 03:53 PM is 0.29
The 52-week high of Vaishali Pharma Ltd is ₹ 119.30 while the 52-week low is ₹ 28.95 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE